Navamedic ASA: Mandatory notice of trade
Navamedic ASA (NAVA) · publisert 14. februar 2025 kl. 16:47 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass |
|---|---|---|---|---|---|---|---|
| Philip Slätis | Primary insider: Commercial Director | Kjøp | 4 700 | 22,19 NOK | 14. februar 2025 | – | Oslo Stock Exchange |
Vedlegg
- Notification_of_trade.pdf (application/pdf, originaldokument)
Meldingstekst
Oslo, February 14, 2025: Philip Slätis, Commercial Director and a primary
insider of Navamedic ASA, has today bought 4,700 Navamedic ASA shares at an
average price of NOK 22,19 per share. See attachment for further details about
the transaction. Following this transaction, Philip Slätis holds 4,703 shares
in the company.
This release is an announcement issued pursuant to legal information obligations
and is subject of the disclosure requirements pursuant to the Market Abuse
Regulation (MAR) Article 19 no. 3 and section 5-12 of the Norwegian Securities
Trading Act